A citation-based method for searching scientific literature

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi. J Clin Oncol 2015
Times Cited: 606



Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Frédéric Selle, Jalid Sehouli, Domenica Lorusso, Eva M Guerra Alía, Alexander Reinthaller, Shoji Nagao, Claudia Lefeuvre-Plesse, Ulrich Canzler, Giovanni Scambia, Alain Lortholary, Frederik Marmé, Pierre Combe, Nikolaus de Gregorio, Manuel Rodrigues, Paul Buderath, Coraline Dubot, Alexander Burges, Benoît You, Eric Pujade-Lauraine, Philipp Harter. N Engl J Med 2019
Times Cited: 304




List of shared articles



Times cited

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease.
Rebecca C Arend, Amy Jackson-Fisher, Ira A Jacobs, Jeffrey Chou, Bradley J Monk. Cancer Biol Ther 2021
0

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01).
Yong Jae Lee, Myong Cheol Lim, Byoung Gie Kim, Natalie Yl Ngoi, Chel Hun Choi, Sang Yoon Park, David Sp Tan, Yunjung Go, Jung Yun Lee. J Gynecol Oncol 2021
1

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy.
Wen-Wei Lin, Yi-An Cheng, Chia-Ching Li, Kai-Wen Ho, Huei-Jen Chen, I-J U Chen, Bo-Cheng Huang, Hui-Ju Liu, Yun-Chi Lu, Chiu-Min Cheng,[...]. Sci Rep 2021
0

Frontline Maintenance Treatment for Ovarian Cancer.
Osnat Elyashiv, Yien Ning Sophia Wong, Jonathan A Ledermann. Curr Oncol Rep 2021
0

A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).
Luca Falzone, Giuseppa Scandurra, Valentina Lombardo, Giuseppe Gattuso, Alessandro Lavoro, Andrea Benedetto Distefano, Giuseppe Scibilia, Paolo Scollo. Int J Oncol 2021
2

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.
Laura Ardighieri, Francesco Missale, Mattia Bugatti, Luisa Benerini Gatta, Irene Pezzali, Matilde Monti, Stefano Gottardi, Laura Zanotti, Eliana Bignotti, Antonella Ravaggi,[...]. Front Immunol 2021
1

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer.
Julie Lecuelle, Romain Boidot, Hugo Mananet, Valentin Derangère, Juliette Albuisson, Vincent Goussot, Laurent Arnould, Zoé Tharin, Isabelle Ray Coquard, François Ghiringhelli,[...]. Cancers (Basel) 2021
0

Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human.
Cheryl Lai-Lai Chiang, Raphaël Rovelli, Apostolos Sarivalasis, Lana E Kandalaft. Cancers (Basel) 2021
0

Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors.
M Bartoletti, L Musacchio, G Giannone, V Tuninetti, A Bergamini, G Scambia, D Lorusso, G Valabrega, G Mangili, F Puglisi,[...]. Cancer Treat Rev 2021
0

Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.
Xin Luo, Jing Xu, Jianhua Yu, Ping Yi. Front Immunol 2021
2